Prefilled autoinjector

DEVICE2 trials

Sponsors

GlaxoSmithKline, Eli Lilly and Company

Conditions

AsthmaHealthy Participants

Phase 1

A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants

CompletedNCT05154968

Eli Lilly and CompanyHealthy Participants

Start: 2021-11-24End: 2021-12-14Updated: 2022-01-13

Phase 3

A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

CompletedNCT03014674

GlaxoSmithKlineAsthma

Start: 2017-01-06End: 2017-08-11Updated: 2019-12-03

Related Papers

The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial

Clinical Pharmacology in Drug Development2019-07-1720 citations